+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Human Reproductive Technologies Market by Assisted Reproductive Technology Type, Application, Fertility Drug Type, Service Provider, End User - Global Forecast 2025-2030- Product Image
Human Reproductive Technologies Market by Assisted Reproductive Technology Type, Application, Fertility Drug Type, Service Provider, End User - Global Forecast 2025-2030- Product Image
Sale

Human Reproductive Technologies Market by Assisted Reproductive Technology Type, Application, Fertility Drug Type, Service Provider, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5887220
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Human Reproductive Technologies Market is evolving rapidly as healthcare providers and industry leaders respond to changing fertility trends, advances in laboratory science, and the growing call for patient-centric care models. Sophisticated technologies and regulatory frameworks are reshaping the competitive landscape, urging stakeholders to align strategies for sustained growth.

Market Snapshot: Human Reproductive Technologies Market

The Human Reproductive Technologies Market grew from USD 31.82 billion in 2024 to USD 33.97 billion in 2025. It is expected to continue growing at a CAGR of 6.68%, reaching USD 46.92 billion by 2030. Key drivers include increased demand for fertility treatments, ongoing adoption of advanced in vitro technologies, and expansion across both developed and emerging healthcare systems. Industry players are prioritizing digital transformation, integrated laboratory solutions, and strategic collaborations to enhance patient outcomes and streamline care pathways.

Scope & Segmentation

This report comprehensively analyzes market segmentation and scope, focusing on breadth of technologies, applications, and user demographics shaping the industry:

  • Assisted Reproductive Technology Type: Includes gamete intrafallopian transfer, in vitro fertilization, intracytoplasmic sperm injection, intrauterine insemination, and zygote intrafallopian transfer.
  • Application: Covers fertility preservation, genetic testing, and infertility treatment, supporting tailored clinical pathways for diverse patient needs.
  • Fertility Drug Type: Encompasses GnRH analogues, gonadotropins, human chorionic gonadotropin, and progesterone therapies aimed at optimized stimulation and support.
  • Service Provider: Analyzes the role of fertility clinics, hospital networks, and research institutes as channels for advanced reproductive care.
  • End User: Assesses distinct requirements of heterosexual couples, LGBTQ couples, and single parents, ensuring inclusivity in patient engagement.
  • Regional Coverage: Investigates market nuances across the Americas, Europe, Middle East & Africa, and Asia-Pacific, highlighting region-specific drivers and approaches.
  • Key Companies: Profiles sector innovators such as Merck KGaA, Ferring Pharmaceuticals, Natera, Inc., and others shaping product development and market presence.

Key Takeaways for Senior Decision-Makers

  • The rise of telehealth and AI-enabled embryo selection is transforming patient access and clinical decision making, creating opportunities for differentiation and real-time care optimization.
  • Stakeholders must adapt to heightened regulatory scrutiny and evolving reimbursement frameworks that demand robust evidence generation and flexible service models.
  • Growing diversity among patient profiles is pushing providers to expand personalized treatment offerings, which includes integrating fertility preservation and psychological support.
  • Strategic collaboration between biotechnology, clinical, and academic partners accelerates translational research, helping to reduce time to market for novel therapies and improve clinical success rates.
  • Manufacturers and service providers are prioritizing supply chain resilience through dual sourcing and optimized logistics, ensuring continuity of care despite global disruption.

Tariff Impact and Supply Chain Response

Recent changes in United States tariff measures on medical reagents and equipment have increased procurement costs for clinics and labs, affecting operational expenses. Domestic manufacturers are scaling capacity, while providers reassess their sourcing strategies for critical consumables. As a result, cost structures and patient accessibility dynamics are shifting, with revised fee models and new reimbursement negotiations. Cross-border patient flows are beginning to reflect adaptation to global trade shifts, and industry associations are actively engaged in seeking exemptions and advocating for sustained access to innovation.

Methodology & Data Sources

This report utilizes a multi-phased research framework integrating qualitative interviews with clinicians, policy experts, and laboratory leaders, combined with rigorous review of peer-reviewed literature, government documents, and current industry data. Strategic segmentation and regional mapping refine the analysis, while expert validation workshops solidify the reliability and actionability of findings.

Why This Report Matters

  • Delivers strategic clarity to inform investment, market entry, and product innovation by connecting regulatory trends to actionable segmentation insights.
  • Empowers decision-makers to navigate complex supply chains and evolving patient demographics with region-specific intelligence and competitor benchmarking.
  • Supports alignment of organizational goals with industry best practices in clinical excellence, resilience, and patient engagement.

Conclusion

The Human Reproductive Technologies Market is marked by continuous innovation, regulatory evolution, and expanding care models. Organizations that align with these trends will be positioned to drive operational excellence, optimize patient outcomes, and secure long-term growth in this dynamic sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of artificial intelligence for automated embryo selection and viability assessment in IVF labs
5.2. Clinical implementation of noninvasive metabolomic profiling for real time embryo quality monitoring
5.3. Expansion of telehealth and remote monitoring platforms for personalized fertility care and consultations
5.4. Development of CRISPR based preimplantation genetic testing for monogenic disorder correction in embryos
5.5. Adoption of at home digital hormone and ovulation testing devices with AI driven predictive analytics
5.6. Advances in 3D printed ovarian tissue scaffolds for fertility restoration and transplantation therapies
5.7. Emergence of blockchain enabled traceability systems for secure gamete and embryo tracking across clinics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Human Reproductive Technologies Market, by Assisted Reproductive Technology Type
8.1. Introduction
8.2. Gamete Intrafallopian Transfer
8.3. In Vitro Fertilization
8.3.1. Fresh Embryo Transfer
8.3.2. Frozen Embryo Transfer
8.4. Intracytoplasmic Sperm Injection
8.5. Intrauterine Insemination
8.6. Zygote Intrafallopian Transfer
9. Human Reproductive Technologies Market, by Application
9.1. Introduction
9.2. Fertility Preservation
9.2.1. Embryo Cryopreservation
9.2.2. Oocyte Cryopreservation
9.2.3. Sperm Cryopreservation
9.3. Genetic Testing
9.3.1. PGT A
9.3.2. PGT M
9.3.3. PGT SR
9.4. Infertility Treatment
10. Human Reproductive Technologies Market, by Fertility Drug Type
10.1. Introduction
10.2. GnRH Analogue
10.3. Gonadotropin
10.4. Human Chorionic Gonadotropin
10.5. Progesterone
11. Human Reproductive Technologies Market, by Service Provider
11.1. Introduction
11.2. Fertility Clinic
11.3. Hospital
11.4. Research Institute
12. Human Reproductive Technologies Market, by End User
12.1. Introduction
12.2. Heterosexual Couple
12.3. LGBTQ Couple
12.4. Single Parent
13. Americas Human Reproductive Technologies Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Human Reproductive Technologies Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Human Reproductive Technologies Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Merck KGaA
16.3.2. Ferring Pharmaceuticals A/S
16.3.3. Progyny, Inc.
16.3.4. Vitrolife AB
16.3.5. Cook Medical LLC
16.3.6. CooperSurgical, Inc.
16.3.7. Natera, Inc.
16.3.8. Illumina, Inc.
16.3.9. Laboratory Corporation of America Holdings
16.3.10. Thermo Fisher Scientific Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET: RESEARCHAI
FIGURE 26. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET: RESEARCHSTATISTICS
FIGURE 27. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET: RESEARCHCONTACTS
FIGURE 28. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GAMETE INTRAFALLOPIAN TRANSFER, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GAMETE INTRAFALLOPIAN TRANSFER, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FRESH EMBRYO TRANSFER, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FRESH EMBRYO TRANSFER, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ZYGOTE INTRAFALLOPIAN TRANSFER, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ZYGOTE INTRAFALLOPIAN TRANSFER, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY EMBRYO CRYOPRESERVATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY EMBRYO CRYOPRESERVATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY OOCYTE CRYOPRESERVATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY OOCYTE CRYOPRESERVATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SPERM CRYOPRESERVATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SPERM CRYOPRESERVATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY PGT A, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY PGT A, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY PGT M, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY PGT M, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY PGT SR, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY PGT SR, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY INFERTILITY TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY INFERTILITY TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GNRH ANALOGUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GNRH ANALOGUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GONADOTROPIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GONADOTROPIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY HUMAN CHORIONIC GONADOTROPIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY HUMAN CHORIONIC GONADOTROPIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY PROGESTERONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY PROGESTERONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY HETEROSEXUAL COUPLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY HETEROSEXUAL COUPLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY LGBTQ COUPLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY LGBTQ COUPLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SINGLE PARENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SINGLE PARENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 113. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 114. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 115. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2024 (USD MILLION)
TABLE 116. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2025-2030 (USD MILLION)
TABLE 117. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2024 (USD MILLION)
TABLE 120. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2025-2030 (USD MILLION)
TABLE 121. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 122. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 123. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 124. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 125. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2024 (USD MILLION)
TABLE 126. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2025-2030 (USD MILLION)
TABLE 127. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 130. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 131. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2024 (USD MILLION)
TABLE 132. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2025-2030 (USD MILLION)
TABLE 133. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2024 (USD MILLION)
TABLE 136. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2025-2030 (USD MILLION)
TABLE 137. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 138. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 139. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 140. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 141. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2024 (USD MILLION)
TABLE 142. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2025-2030 (USD MILLION)
TABLE 143. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 212. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 213. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2024 (USD MILLION)
TABLE 214. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2025-2030 (USD MILLION)
TABLE 215. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2024 (USD MILLION)
TABLE 218. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2025-2030 (USD MILLION)
TABLE 219. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 220. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 221. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 222. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 223. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2024 (USD MILLION)
TABLE 224. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2025-2030 (USD MILLION)
TABLE 225. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 228. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 229. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2024 (USD MILLION)
TABLE 230. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2025-2030 (USD MILLION)
TABLE 231. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2024 (USD MILLION)
TABLE 234. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2025-2030 (USD MILLION)
TABLE 235. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 236. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 237. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 238. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 239. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2024 (USD MILLION)
TABLE 240. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2025-2030 (USD MILLION)
TABLE 241. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 260. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 261. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2024 (USD MILLION)
TABLE 262. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2025-2030 (USD MILLION)
TABLE 263. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2024 (USD MILLION)
TABLE 266. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2025-2030 (USD MILLION)
TABLE 267. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 268. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 269. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 270. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 271. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2024 (USD MILLION)
TABLE 272. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2025-2030 (USD MILLION)
TABLE 273. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. SPAIN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 276. SPAIN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 277. SPAIN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2024 (USD MILLION)
TABLE 278. SPAIN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2025-2030 (USD MILLION)
TABLE 279. SPAIN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. SPAIN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. SPAIN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2024 (USD MILLION)
TABLE 282. SPAIN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2025-2030 (USD MILLION)
TABLE 283. SPAIN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 284. SPAIN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 285. SPAIN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 286. SPAIN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 287. SPAIN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2024 (USD MILLION)
TABLE 288. SPAIN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET S

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Human Reproductive Technologies market report include:
  • Merck KGaA
  • Ferring Pharmaceuticals A/S
  • Progyny, Inc.
  • Vitrolife AB
  • Cook Medical LLC
  • CooperSurgical, Inc.
  • Natera, Inc.
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages194
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 33.97 Billion
Forecasted Market Value ( USD ) by 2030 $ 46.92 Billion
Compound Annual Growth Rate6.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Assisted Reproductive Technology Market (ART) by Technique (Gamete Intrafallopian Transfer, In Vitro Fertilization, Intracytoplasmic Sperm Injection), Cycle Type (Fresh Donor, Fresh Non-Donor, Frozen), Treatment, End User, Product - Global Forecast 2025-2030 - Product Image

Assisted Reproductive Technology Market (ART) by Technique (Gamete Intrafallopian Transfer, In Vitro Fertilization, Intracytoplasmic Sperm Injection), Cycle Type (Fresh Donor, Fresh Non-Donor, Frozen), Treatment, End User, Product - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Sperm Banks Market by Application (Assisted Reproductive Technology, Donor Insemination, Fertility Preservation), Service (Consultation, Distribution And Transportation, Storage), Donor Type, End User, Payment Mode - Global Forecast 2025-2030 - Product Image

Sperm Banks Market by Application (Assisted Reproductive Technology, Donor Insemination, Fertility Preservation), Service (Consultation, Distribution And Transportation, Storage), Donor Type, End User, Payment Mode - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Assisted Reproductive Technology Market Report and Forecast 2025-2034 - Product Image

Assisted Reproductive Technology Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Assisted Reproductive Technology - Global Strategic Business Report - Product Image

Assisted Reproductive Technology - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Human Reproductive Technologies - Global Strategic Business Report - Product Image

Human Reproductive Technologies - Global Strategic Business Report

  • Report
  • 167 Pages
  • Global
From

About the Human Reproductive Technologies Market

The Human Reproductive Technologies market is a subset of the Sexual and Reproductive Health Drugs market. It includes products and services related to fertility, contraception, and assisted reproductive technologies. These technologies are used to help individuals and couples conceive, prevent pregnancy, and manage reproductive health. They include fertility treatments such as in vitro fertilization (IVF), intrauterine insemination (IUI), and ovulation induction, as well as contraception methods such as birth control pills, intrauterine devices (IUDs), and male and female condoms. Assisted reproductive technologies include egg and sperm donation, surrogacy, and preimplantation genetic diagnosis (PGD). Some companies in the Human Reproductive Technologies market include Ferring Pharmaceuticals, Merck, Bayer, and CooperSurgical. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.